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Chondrosarcoma is the second most common primary malignant bone tumour. Distinguishing between grades is not necessarily
straightforward and may alter the disease management. We evaluated the correlation between histological grading of the
preoperative image-guided needle biopsy and the resection specimen of 78 consecutive cases of chondrosarcoma of the femur,
humerus, and tibia. In 11 instances, there was a discrepancy in histological grade between the biopsy and surgical specimen.
Therefore, there was an 85.9% (67/78) accuracy rate for pre-operative histological grading of chondrosarcoma, based on
needle biopsy. However, the accuracy of the diagnostic biopsy to distinguish low-grade from high-grade chondrosarcoma was
93.6% (73/78). We conclude that accurate image-guided biopsy is a very useful adjunct in determining histological grade
of chondrosarcoma and the subsequent treatment plan. At present, a multidisciplinary approach, comprising experienced
orthopaedic surgeons, radiologists, and pathologists, offers the most reliable means of accurately diagnosing and grading of
chondrosarcoma of long bones.
1. Introduction
Chondrosarcoma is the second most common primary
malignant bone tumour, exceeded in frequency only by
osteosarcoma [1–6]. There are three well-recognised histo-
logical grades, which may influence the choice of appropriate
management [7]. Unfortunately, distinguishing between
grades from pre-operative image-guided biopsy is not nec-
essarily straightforward [8–13]. Choice of management in
such cases depends on a combination of history, clinical
examination, and radiological findings.
Histologically, chondrosarcomas may be classified into
three groups according to cellularity and pleomorphism
(I, II, and III) or may be referred to as dedifferentiated
chondrosarcomas [14]. Clinically, chondrosarcomas are sub-
divided into low grade (I) and high grade (II, III, and ded-
ifferentiated). Overall five-year survival has been reported
as 75% [15]. Low-grade lesions tend to be slow growing,
metastasise infrequently, and are associated with a 90% five-
year survival rate, which plateaus after this period [16]. They
are commonly treated by curettage with bone cement [17–
19], although some authors describe a high mortality risk
after intralesional resection (including curettage) in their
reports [6, 16]. High-grade tumours have a higher incidence
of metastasis, with a variably reported five-year survival rate
of 40%–80%for grades II-III, but significantly inferior for
dedifferentiated tumours [7, 14]. This figures plateau’s at
approximately 20% survival beyond 10 years [16, 20]. Most
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are treated with wide excision (with the margins confirmed
histologically postoperatively) and reconstruction [7, 18, 21].
The main aim of this study was to determine the
accuracy of pre-operative image-guided needle biopsy in
suspected chondrosarcoma of long bones, thus allowing an
evaluation of the reliability of image-guided needle biopsy
for planning surgical management. We restricted the study
to chondrosarcoma of the long bones given the relative ease
of obtaining an adequate biopsy sample from these locations
compared to those tumours located within the pelvis or
other parts of the axial skeleton. Furthermore, the treatment
options for such tumours may differ significantly from those
located in the long bones.
2. Materials and Methods
We retrospectively reviewed the tumour database at a
supraregional bone and soft tissue tumour unit. We exam-
ined the records of all cases of chondrosarcoma diagnosed on
needle biopsy, identifying 124 patients. Cases of chondrosar-
coma that did not undergo needle biopsy were excluded.
Cases where the biopsy was inconclusive (the rate at our
institution is 5.2% for all biopsies) or did not give a diag-
nosis of chondrosarcoma were not considered. We excluded
tumours not located within the femur, tibia, or humerus (31
pelvic/sacral, 5 forearm/hand, 4 rib, 3 shoulder, 2 sternum,
and 1 foot) leaving 78 patients with chondrosarcoma of
these long bones. All specimens were analysed by experienced
dedicated musculoskeletal tumour Pathologists, with the
diagnosis and grade given by consensus opinion.
The mean age at presentation was 52 years old (range
10–87 years). The female-to-male ratio was 45 : 33. The
most common tumour location was the femur (n = 45),
followed by the humerus (n = 24) and tibia (n = 9). Stan-
dard radiological investigations included plain radiographs,
computed tomography (CT), whole-body bone scintigraphy
and magnetic resonance imaging (MRI). All of the tumours
were primary chondrosarcomas.
All patients underwent a pre-operative biopsy using a
Jamshidi needle, to assist planning of further management.
All biopsy approaches were preplanned following discussion
with referring surgeons and were performed by specialist
radiologists under fluoroscopic or CT guidance. Following
departmental policy, all those graded as high grade from
the needle biopsy were surgically excised. Tumours graded
as low grade were treated either by curettage with bone
cement (mostly small, slow-growing, or peri-articular) or by
excision (large, rapidly growing or those tumours for which
resection and reconstruction was relatively straightforward)
dependant upon multidisciplinary discussion.
The histopathological diagnosis and grade were under-
taken in all cases by experiencedmusculoskeletal pathologists
and were based on the light microscopic features according
to the World Health Organisation [22]. The histological
grade based on needle biopsy and surgical specimens was
compared by reviewing the histology reports. Where the
biopsy showed a mixed grade, the higher grade was taken as
the final grading.
The research was performed following the Declaration of
Helsinki principles. Informed consent was obtained from all
research subjects.
3. Results
After exclusions, 78 long bone chondrosarcoma cases
remained. In 67 cases, there was agreement between the
needle biopsy histological grade and the final histological
grade based on the resection specimen, giving an 86%
(67/78) accuracy rate for needle biopsy. In 11 instances, there
was a discrepancy in histological grade (Table 1). In 9 of
these, the surgical histology revealed a higher grade than that
evident from the needle biopsy histology. In 2 cases, a higher
grade was attributed to the needle biopsy histology compared
to the surgical histology.
When considering the mismatch between clinically low-
grade and high-grade lesions, only 5 of the 11 cases
with a discrepancy in histological grade were diagnosed as
low grade on needle biopsy, but high grade on surgical
histology. Therefore, the accuracy of the diagnostic biopsy to
distinguish low-grade from high-grade chondrosarcoma was
94% (73/78).
4. Discussion
Chondrosarcoma comprises 10%–15% of all primary bone
tumours and can be defined as a malignant tumour whose
cells produce hyaline cartilage, usually in a lobular growth
pattern. Despite a clear relationship between histological
grade and prognosis, the clinical course of chondrosarcoma
can be unpredictable [2, 4, 5, 16, 17, 23–25].
Needle biopsy is usually essential for the specific diag-
nosis of a bone lesion and will often allow an accurate
histological grade to be determined, thereby helping guide
further management. The literature indicates that the accu-
racy of histological grading from needle biopsies of bone
tumours in general is between 80% and 86% [8–10]. Lerma
et al. [26] report 85% concordance between cytology and
histology specimens from 39 cases of chondrosarcoma,
although Kreicbergs et al. describe the greatest difficulty of all
bone tumours in diagnosing chondrosarcoma correctly [9].
In order to achieve this accuracy, precise image guidance is
required at the time of biopsy. An experienced pathologist
who is able to confirm the diagnosis and provide the tumour
grade from small tissue samples is also essential. It should
be stressed that biopsy does have associated problems. It is
painful, expensive and the biopsy tract requires excision at
the time of operation [27, 28]. Therefore when diagnosis and
management are not in doubt, biopsy may be avoided.
In our centre, the accuracy of exact histological grading
of long bone chondrosarcoma based on image guided needle
biopsy was 86% (67/78 cases). However, when classed
clinically as either low or high grade, the accuracy was
close to 94% (73/78). Grading into these two significant
different clinical entities is critical and more important
than the exact histological grade, as the treatment regimen
for low- and high-grade tumours may markedly differ.
International Journal of Surgical Oncology 3
Table 1: Summary of case histories, histology diagnosis, and management of patients with discrepancy in histological grade (F: femur; H:
humerus).
Case Gender Age Bone Pre-op biopsy Excision biopsy Surgery Local recurrence
1 Male 30 F Low-grade (II) High-grade (III) Excision No
2 Male 24 F High-grade
(I-II-III)
Low-grade (I-II)
Curettage with
bone cement
No
3 Female 77 H Low-grade (II)
High-grade
(I-II-III)
Excision No
4 Female 54 F Low-grade (II) Low-grade (I) Excision No
5 Female 10 F Chondroblastic
osteosarcoma
High-grade
chondrosarcoma
(III)
Excision No
6 Male 65 F Low-grade (I) Low-grade (I-II) Excision No
7 Male 51 H Low-grade (II) High-grade (II-III) Excision No
8 Female 50 F Low-grade (I) Low-grade (I-II) Excision No
9 Male 28 F Low-grade (I) High-grade (II-III) Excision No
10 Male 63 F High-grade (III)
Dedifferentiated
chondrosarcoma
Excision No
11 Female 20 F Low-grade (I) Low-grade (I-II) Excision No
Undergrading of tumours may lead to inadequate surgical
treatment and increased risk of local recurrence, metastases
and subsequent mortality. Overgrading of tumours could
bring about inappropriate use of more invasive surgical
treatments with the increased risks of surgical complications,
psychological morbidity, loss of function, and poor cosmesis.
On review of the surgical histology, all 78 cases that
underwent pre-operative needle biopsy received an appropri-
ate surgical intervention. In all cases the grading of the needle
biopsy was critical in determining the treatment plan. The
67 cases where the exact grade of the tumour was correctly
identified from the needle biopsy, all received an appropriate
surgical intervention. In the 11 cases where there was a
mismatch between the needle biopsy and excision specimen
histological grading, no inappropriate surgical intervention
occurred. The mismatch in only five of these 11 cases meant
a reclassification from low grade to high grade. Ten of
these tumours were excised primarily and one was treated
by curettage with bone cement (this case was ultimately
classified as low grade). None of these cases required any
subsequent surgical procedures related to their chondrosar-
coma. We attribute this successful decision-making to the
multidisciplinary approach used. This includes a team of
experienced orthopaedic oncology surgeons, radiologists
and pathologists, which greatly assists in pre-operative diag-
nosis and planning. In two of the cases, the histological grade
of the needle biopsy overestimated the grade of the tumour.
Surgical excision of one of these lesions was undertaken,
and the remaining tumour was treated by curettage with
bone cement. Both cases are under careful observation
with clinical examination and further imaging at regular
intervals. For the remaining nine mismatched cases where
the needle biopsy suggested a lower-grade diagnosis than the
subsequent excision histology revealed, the multidisciplinary
team concluded during pre-operative surgical planning that
all should subsequently undergo surgical excision rather than
curettage with bone cement. In these cases, the treatment
decision to err on the side of caution was taken on the
basis of the history, clinical examination, and radiographic
findings specific to each individual patient as well as the
histopathological features. Again, we consider this successful
decision making to be a result of discussion between an
experienced multidisciplinary team.
We restricted our study to chondrosarcoma of the femur,
tibia, and humerus, excluding those tumours occurring
in other locations. Such other tumours, particularly those
occurring within the pelvis or axial skeleton, may be subject
to differing treatment options. Whilst a needle biopsy is still
essential in accurately diagnosing the tumour grade, these
lesions may be treated differently to their counterparts of
identical grade in the long bones that we have included in
our study, and direct comparison therefore should be looked
upon cautiously.
The most likely explanation for the mismatches in
grading that we identified is the well-described heterogeneity
of chondrosarcoma lesions and the incumbent sampling
difficulties related to this. In the cases where the tumour
grade was underestimated, it is likely that the tissue sampled
by these needle biopsies represented lower-grade segments
of the lesions without sampling the more malignant parts.
The reason for the two overestimate discrepancies is unclear,
but such cases highlight the potential intra- and interob-
server difficulties of chondrosarcoma grade classification.We
accept that the mismatches could be explained by human
error in interpretation of the specimens at a pathological
level, or suboptimal biopsy tissue samples. It is clear that an
adequate biopsy tissue sample is essential tomake an accurate
diagnosis.
We conclude that accurate image-guided biopsy is a
very useful adjunct in determining the histological grade
of chondrosarcoma and the subsequent treatment plan.
At present, a multidisciplinary approach offers the most
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reliable means of accurately diagnosing and grading of
chondrosarcoma of long bones.
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